![John Richards](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Richards
Vorsitzender bei
AKTIENBRAUEREI KAUFBEUREN AG
Profil
John D.
Richards is currently Chairman-Supervisory Board at Aktienbrauerei Kaufbeuren AG since 2022 and Chief Scientific Advisor at Comanche Biopharma Corp.
Former positions include Director-Process Development & Manufacturing at ImmuLogic Pharmaceutical Corp.
from 1993 to 1997, Non-Executive Director at Aptamer Group Plc, Vice President at The Medicines Co. from 1997 to 2013, Technical Manager at Zeneca Group Plc from 1989 to 1993, Senior Vice President at Novartis Pharmaceuticals Corp., and Vice President-Manufacturing Operations at Panacos Pharmaceuticals, Inc. from 2006 to 2009.
Education includes undergraduate, graduate, and doctorate degrees from the University of Oxford.
Aktive Positionen von John Richards
| Unternehmen | Position | Beginn |
|---|---|---|
| AKTIENBRAUEREI KAUFBEUREN AG | Vorsitzender | 30.09.2022 |
Comanche Biopharma Corp.
 Comanche Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical biopharmaceutical company which develops a novel siRNA therapy for the treatment of preeclampsia | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von John Richards
| Unternehmen | Position | Ende |
|---|---|---|
| APTAMER GROUP PLC | Direktor/Vorstandsmitglied | 21.08.2023 |
| PANACOS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 13.02.2009 |
ImmuLogic Pharmaceutical Corp.
 ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01.10.1997 |
Zeneca Group Plc
 Zeneca Group Plc Pharmaceuticals: MajorHealth Technology Develops & manufactures pharmaceutical products, agrochemicals and speciality chemicals | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1993 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Corporate Officer/Principal | - |
Ausbildung von John Richards
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
43
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
ImmuLogic Pharmaceutical Corp.
ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for acute cardiovascular care | Health Technology |
Aktienbrauerei Kaufbeuren AG
 Aktienbrauerei Kaufbeuren AG Real Estate DevelopmentFinance Engages in the leasing, management, and acquisition of real estate properties | Finance |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zeneca Group Plc
Zeneca Group Plc Pharmaceuticals: MajorHealth Technology Develops & manufactures pharmaceutical products, agrochemicals and speciality chemicals | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Panacos Pharmaceuticals, Inc.
 Panacos Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small molecule drugs | Health Technology |
Aptamer Group Plc
 Aptamer Group Plc BiotechnologyHealth Technology Engages in research and development of biotechnology products | Health Technology |
Comanche Biopharma Corp.
Comanche Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical biopharmaceutical company which develops a novel siRNA therapy for the treatment of preeclampsia | Commercial Services |
